| Appropriate Public Health Response to Foodborne Illness | Breakout Session II – Appropriate Public Health Response to Foodborne Illness: Discrepancies Among States’ Surveillance of Foodborne Illness and Implications for Attribution. Click here to view the powerpoint presentation. | |
WHO Conference in Geneva, Switzerland |
S.T.O.P. President Nancy Donley Spoke in Geneva, Switzerland (11.20.08) at the World Health Organization Meeting on The Global Burden of Foodborne Disease. Click here to see the powerpoint presentation. |  |
| Ten Year Report | January of 2003 marked the ten year anniversary of the Jack in the Box E. coli O157:H7 outbreak and S.T.O.P. released a commemorative report, “Why Are People Still Dying From Contaminated Food?” The goal of the well-received report was to provide a compelling and comprehensive view of the systemic gaps that allow foodborne disease to continue to kill and harm millions of American families every year. The report also lists dozens of specific recommendations for policy improvements in all areas to improve food safety and public health response. Click here to see the Ten Year Report. | |
| Victim Conference | In July, 2003, S.T.O.P. held the first Advocates and Victims’ Conference in Madison, Wisconsin. Victims, public health officials, policy advocates, and concerned individuals gathered for three days and expert speakers provided a wealth of insight and information. Presentations included educational pointers on how to present stories to the media, how community organizing can bring about change, a primer on politics, government agencies and food safety, and a study on foodborne illness patients’ experiences with the U.S. public health system. |
|
On October 7, 2000, S.T.O.P. held a conference in Seattle on “Long-Term Implications of Hemolytic Uremic Syndrome: A Multi-Disciplinary Conference for Survivors of E. coli O157:H7, Their Parents, and Physicians.” Leading world experts gave presentations about the impact of E. coli’s verotoxin and the HUS it causes on a wide variety of body systems: gastrointestinal, pancreatic, kidney, heat, nervous system (and accompanying neuropsychological problems). A discussion of the use of plasma pheresis in treating TTP reviewed the current (2000) treatment and follow-up care available to patients in Canada. One benefit of the conference was that it increased awareness amongst the HUS “expert” community about the concerns of HUS patients. There were 58 attendees who were related to HUS patients and the medical speakers expressed an interest in improving treatment and follow-up nationally for HUS patients. Please click on the links below to view the presentations. Welcome and Introduction by Nancy Donley, President, S.T.O.P.- Safe Tables Our Priority The Basis of the Acute Phase of Verotoxin-Induced HUS: Molecular Risk Factors by Clifford A. Lingwood, PhD Plasma Exchange in the Treatment of TTP/HUS with Long-Term Follow Up and Prognosis by Gail Rock, PhD, MD, FRCP First Question and Answer Period Escherichia coli O157:H7 of the GI Tract; Complications Beyond Diarrhea by Phillip A. Tarr, MD Diabetes and HUS by Richard S. Mauseth, MD Second Question and Answer Period Long-Term Renal Outcomes in Diarrhea-Associated HUS by John Brandt, MD, MPH Long-Term Consequences of HUS: The ENCHLOSE Network (European Network for Childhood HUS Longterm Sequelae) by Piero Ruggeneneti, MD Third Question and Answer Period Hemolytic Uremic Syndrome. The ‘eart of the Matter by Gary Cornel, MB, BS, FRCS (C) Neuropsychological Sequelae of Hemolytic Uremic Syndrome: A Positive Outcome by Elaine Orrbine |
||
| HUS Conference | ||
